DATAcc by DiMe launches core measures for sleep

The Digital Health Measurement Collaborative Community (DATAcc), led by the Digital Medicine Society (DiMe), has introduced a groundbreaking collection of digital measures and resources focused on sleep. Crafted by a multidisciplinary team of experts, these tools aim to streamline and elevate sleep assessments conducted in real-world settings, fostering advancements in both research and patient care across diverse disease domains.

This initiative marks a pivotal stride toward harnessing digital technologies to deepen our understanding of the intricate interplay between sleep patterns, overall health, and various medical conditions. The unveiling of these standardised measures represents a significant leap forward in facilitating more accessible, cost-effective, and representative sleep data collection, paving the way for enhanced interventions and treatment strategies. 

Jennifer Goldsack, CEO of DiMe, underscored the transformative potential of these resources, highlighting their role in democratising access to sleep-related data in clinical trials and healthcare settings. Michael Kremliovsky, Sr. Director of Medical Devices & eHealth at Bayer, echoed this sentiment, emphasising the collaborative effort required to advance innovative approaches to sleep measurement and translate research findings into tangible patient benefits. Noteworthy collaborators in this endeavour include prominent institutions and digital solutions providers, all united in driving forward the adoption of digital endpoints to propel progress in clinical research and patient care. 

Moreover, recent findings from a joint study conducted in partnership with Tufts Center for the Study of Drug Development and industry leaders underscore the compelling cost-effectiveness and financial advantages associated with leveraging digital endpoints in clinical trials. Building on this momentum, DiMe is poised to launch new initiatives aimed at empowering innovators to embrace digital endpoints and accelerate their widespread adoption in clinical research endeavours.

Click here to read the original news story.